Overview

The Therapeutic Goods Act 1989 is a foundational piece of Australian legislation aimed at regulating therapeutic goods, including medical devices, to ensure their safety, quality, and efficacy. The Medical Device Standards Order No. 1, made in 2003 under the authority of the Therapeutic Goods Act 1989, specifically addresses the need for standardised clinical evidence for medical devices. This legislative instrument was enacted by Rita Maclachlan, acting as a delegate of the Minister for Health and Ageing, to establish medical device standards that ensure compliance with the essential principles. The primary policy objective is to safeguard public health by setting rigorous standards for the clinical investigation of medical devices, thus enhancing the reliability and safety of therapeutic goods available in the market. The order ensures that medical devices, particularly cardiac valve prostheses and intraocular lenses, adhere to internationally recognised standards, thereby treating compliant devices as meeting the essential principles specified in the Act.

Scope and Application

The Therapeutic Goods Act 1989 governs the regulation of therapeutic goods in Australia, including medical devices. The Medical Device Standards Order No. 1, which establishes specific standards for clinical evidence, applies to all kinds of medical devices, as well as cardiac valve prostheses and intraocular lenses, each with their respective standards. These standards pertain to the clinical investigations necessary for human subjects, ensuring that such devices meet the essential principles for safety and efficacy. This legislation applies to all entities involved in the manufacture, supply, or importation of medical devices in Australia, ensuring compliance with national standards and facilitating their registration with the Therapeutic Goods Administration. The standards set out in the Order are designed to ensure that medical devices are safe and effective, with specific requirements for cardiac valve prostheses and intraocular lenses. The Order does not explicitly state any exclusions or exemptions, but compliance is contingent upon meeting the specified conditions and standards outlined in the Schedule. The application of these standards is comprehensive, covering the entire spectrum of medical devices within the Australian jurisdiction.

Key Provisions

The Medical Device Standards Order No. 1 under the Therapeutic Goods Act 1989 sets out specific standards for the clinical evidence of medical devices. Section 1(a) establishes that the standards specified in column 2 of item 1 in the Schedule apply to all kinds of medical devices, provided they meet the conditions outlined in column 3. Additionally, section 1(b) specifies that the standards for cardiac valve prostheses and intraocular lenses are those mentioned in column 2 of items 2 and 3, respectively. These standards are intended to ensure that the devices comply with the essential principles detailed in column 4 of the relevant item of the Schedule. The Act imposes several obligations on parties involved in the manufacture, supply, or importation of medical devices. Firstly, manufacturers and suppliers must ensure that their devices meet the specified standards, as outlined in the Schedule. This includes conducting clinical investigations in accordance with the standards detailed in the Act, such as AS EN 540-2002 or AS ISO 14155-2002 for general medical devices. For cardiac valve prostheses, compliance with ISO 5840:1996 is required, while intraocular lenses must adhere to ISO 11979-7:2001. Failure to comply with these standards could result in the devices not being considered compliant with the essential principles of the Therapeutic Goods Act 1989. Breach of the provisions set forth in the Medical Device Standards Order No. 1 can result in serious consequences. The Therapeutic Goods Act 1989 outlines penalties for non-compliance, which can include both civil and criminal penalties. The maximum penalties for contravening the Act can include substantial fines and, in some cases, imprisonment. Specifically, the Act provides for fines of up to $1.1 million for corporations and $220,000 for individuals, alongside potential criminal penalties where the contravention is deemed serious enough. These stringent measures underscore the importance of adhering to the specified medical device standards to ensure the safety and efficacy of therapeutic goods in Australia.